You J - Search Results

1

Metformin synergistically suppress tumor growth with doxorubicin and reverse drug resistance by inhibiting the expression and function of P-glycoprotein in MCF7/ADR cells and xenograft models.

Li Y, Wang M, Zhi P, You J, Gao JQ. Li Y, et al. Among authors: you j. Oncotarget. 2017 Dec 8;9(2):2158-2174. doi: 10.18632/oncotarget.23187. eCollection 2018 Jan 5. Oncotarget. 2017. PMID: 29416762 Free PMC article.

2

Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes.

Li Q, Tang Q, Zhang P, Wang Z, Zhao T, Zhou J, Li H, Ding Q, Li W, Hu F, Du Y, Yuan H, Chen S, Gao J, Zhan J, You J. Li Q, et al. Among authors: you j. Biomaterials. 2015 Jul;57:1-11. doi: 10.1016/j.biomaterials.2015.04.009. Epub 2015 Apr 21. Biomaterials. 2015. PMID: 25956192

3

High efficiency intracellular transport of cationic peptide stearate for gene delivery in tumor cells and multipotent stem cells.

Shan CL, Huang B, You J, Yuan H, Gao JQ, Hu FQ, Du YZ. Shan CL, et al. Among authors: you j. J Biomed Nanotechnol. 2014 Nov;10(11):3231-43. doi: 10.1166/jbn.2014.1860. J Biomed Nanotechnol. 2014. PMID: 26000383

4

Chitosan nanoparticles and their Tween 80 modified counterparts disrupt the developmental profile of zebrafish embryos.

Yuan Z, Li Y, Hu Y, You J, Higashisaka K, Nagano K, Tsutsumi Y, Gao J. Yuan Z, et al. Among authors: you j. Int J Pharm. 2016 Dec 30;515(1-2):644-656. doi: 10.1016/j.ijpharm.2016.10.071. Epub 2016 Nov 5. Int J Pharm. 2016. PMID: 27826026

5

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery.

Li Y, Wang M, Huang BW, Ping Y, You J, Gao JQ. Li Y, et al. Among authors: you j. Int J Nanomedicine. 2017 Nov 29;12:8557-8572. doi: 10.2147/IJN.S148975. eCollection 2017. Int J Nanomedicine. 2017. PMID: 29238192 Free PMC article.

6

A photosensitive liposome with NIR light triggered doxorubicin release as a combined photodynamic-chemo therapy system.

Li Q, Li W, Di H, Luo L, Zhu C, Yang J, Yin X, Yin H, Gao J, Du Y, You J. Li Q, et al. Among authors: you j. J Control Release. 2018 May 10;277:114-125. doi: 10.1016/j.jconrel.2018.02.001. Epub 2018 Feb 3. J Control Release. 2018. PMID: 29408424

7

Co-Delivery of Metformin Enhances the Antimultidrug Resistant Tumor Effect of Doxorubicin by Improving Hypoxic Tumor Microenvironment.

Li Y, Luo J, Lin MT, Zhi P, Guo WW, Han M, You J, Gao JQ. Li Y, et al. Among authors: you j. Mol Pharm. 2019 Jul 1;16(7):2966-2979. doi: 10.1021/acs.molpharmaceut.9b00199. Epub 2019 May 30. Mol Pharm. 2019. PMID: 31095914

8

Improved cytotoxicity of doxorubicin by enhancing its nuclear delivery mediated via nanosized micelles.

You J, Hu FQ, Du YZ, Yuan H. You J, et al. Nanotechnology. 2008 Jun 25;19(25):255103. doi: 10.1088/0957-4484/19/25/255103. Epub 2008 May 14. Nanotechnology. 2008. PMID: 21828645

9

Photothermal-chemotherapy with doxorubicin-loaded hollow gold nanospheres: A platform for near-infrared light-trigged drug release.

You J, Zhang R, Zhang G, Zhong M, Liu Y, Van Pelt CS, Liang D, Wei W, Sood AK, Li C. You J, et al. J Control Release. 2012 Mar 10;158(2):319-28. doi: 10.1016/j.jconrel.2011.10.028. Epub 2011 Oct 28. J Control Release. 2012. PMID: 22063003 Free PMC article.

10

pH triggered doxorubicin delivery of PEGylated glycolipid conjugate micelles for tumor targeting therapy.

Hu FQ, Zhang YY, You J, Yuan H, Du YZ. Hu FQ, et al. Among authors: you j. Mol Pharm. 2012 Sep 4;9(9):2469-78. doi: 10.1021/mp300002v. Epub 2012 Aug 7. Mol Pharm. 2012. PMID: 22827551

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,773 results

Search Page

Filters